Karen Y Kuo, MD
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kuo’s office at (408) 972-6931 to ask if they take your plan before you enroll.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Drugs they prescribed that Part D paid
$141,551
Pharmacies billed $141,551 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 264) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
224 generic and 40 brand-name prescriptions · $141,551 in drug cost · 16 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel | 12 | $58,362 | $4,864 |
| Clobetasol Propionate | 41 | $1,301 | $32 |
| Ketoconazole | 30 | $538 | $18 |
| Triamcinolone Acetonide | 17 | $298 | $18 |
| Hydroxyzine | 18 | $180 | $10 |
See all 6 drugs
| Enbrel | 12 | $58,362 | $4,864 |
| Clobetasol Propionate | 41 | $1,301 | $32 |
| Ketoconazole | 30 | $538 | $18 |
| Triamcinolone Acetonide | 17 | $298 | $18 |
| Hydroxyzine | 18 | $180 | $10 |
| Mupirocin | 11 | $152 | $14 |
Year by year
| 2024 | 264 | 98 | 0% (0) | 15% | $141,551 |
| 2023 | 442 | 153 | 0% (0) | 19% | $242,547 |
| 2022 | 278 | 121 | 0% (0) | 15% | $140,764 |
| 2021 | 522 | 226 | 0% (0) | 14% | $205,884 |
| 2020 | 577 | 273 | 0% (0) | 10% | $81,610 |
| 2019 | 610 | 274 | 0% (0) | 13% | $125,680 |
| 2018 | 302 | 148 | 0% (0) | 11% | $50,823 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Enbrel | 13 | $65,466 | $5,036 |
| Otezla | 13 | $55,672 | $4,282 |
| Dupixent | 13 | $44,870 | $3,452 |
| Betamethasone Diprop Augmented | 23 | $2,167 | $94 |
| Clobetasol Propionate | 42 | $1,554 | $37 |
| Tacrolimus | 14 | $1,361 | $97 |
| Fluocinonide | 14 | $817 | $58 |
| Ketoconazole | 40 | $756 | $19 |
| Doxycycline Monohydrate | 12 | $687 | $57 |
| Fluorouracil | 15 | $598 | $40 |
| Triamcinolone Acetonide | 35 | $570 | $16 |
| Desonide | 15 | $300 | $20 |
| Metronidazole | 13 | $285 | $22 |
| Methotrexate | 12 | $184 | $15 |
| Mupirocin | 11 | $143 | $13 |
| Levocetirizine Dihydrochloride | 13 | $127 | $10 |
| Hydroxyzine | 14 | $119 | $9 |
2022: 8 drugs
| Enbrel | 12 | $61,779 | $5,148 |
| Dupixent | 13 | $42,985 | $3,307 |
| Clobetasol Propionate | 44 | $2,207 | $50 |
| Tacrolimus | 13 | $1,717 | $132 |
| Triamcinolone Acetonide | 37 | $1,020 | $28 |
| Fluocinonide | 15 | $785 | $52 |
| Ketoconazole | 26 | $520 | $20 |
| Hydroxyzine | 14 | $118 | $8 |
2021: 12 drugs
| Enbrel | 12 | $59,001 | $4,917 |
| Humira | 11 | $46,643 | $4,240 |
| Clobetasol Propionate | 84 | $5,889 | $70 |
| Fluocinonide | 45 | $2,593 | $58 |
| Triamcinolone Acetonide | 75 | $2,250 | $30 |
| Pimecrolimus | 12 | $2,184 | $182 |
| Tacrolimus | 20 | $2,050 | $103 |
| Fluorouracil | 22 | $1,331 | $61 |
| Ketoconazole | 29 | $806 | $28 |
| Doxycycline Monohydrate | 12 | $545 | $45 |
| Prednisone | 15 | $286 | $19 |
| Hydroxyzine | 21 | $193 | $9 |
2020: 12 drugs
| Clobetasol Propionate | 161 | $11,248 | $70 |
| Acitretin | 21 | $9,117 | $434 |
| Fluorouracil | 63 | $4,103 | $65 |
| Pimecrolimus | 13 | $2,920 | $225 |
| Fluocinonide | 40 | $2,256 | $56 |
| Vectical | 14 | $2,030 | $145 |
| Triamcinolone Acetonide | 61 | $1,027 | $17 |
| Betamethasone Diprop Augmented | 11 | $895 | $81 |
| Metronidazole | 14 | $838 | $60 |
| Doxycycline Monohydrate | 16 | $755 | $47 |
| Ketoconazole | 23 | $509 | $22 |
| Hydroxyzine | 18 | $172 | $10 |
2019: 13 drugs
| Otezla | 15 | $46,215 | $3,081 |
| Clobetasol Propionate | 146 | $13,627 | $93 |
| Acitretin | 14 | $4,192 | $299 |
| Fluorouracil | 44 | $3,203 | $73 |
| Fluocinonide | 40 | $2,350 | $59 |
| Betamethasone Diprop Augmented | 22 | $2,221 | $101 |
| Doxycycline Monohydrate | 25 | $2,028 | $81 |
| Triamcinolone Acetonide | 71 | $1,672 | $24 |
| Metronidazole | 12 | $609 | $51 |
| Ketoconazole | 15 | $322 | $21 |
| Mupirocin | 15 | $264 | $18 |
| Methotrexate | 17 | $261 | $15 |
| Hydroxyzine | 19 | $148 | $8 |
2018: 9 drugs
| Clobetasol Propionate | 61 | $6,772 | $111 |
| Fluorouracil | 20 | $2,204 | $110 |
| Triamcinolone Acetonide | 41 | $1,846 | $45 |
| Fluocinonide | 14 | $1,142 | $82 |
| Methotrexate | 11 | $363 | $33 |
| Hydrocortisone | 14 | $287 | $20 |
| Prednisone | 14 | $271 | $19 |
| Ketoconazole | 12 | $243 | $20 |
| Hydroxyzine | 22 | $172 | $8 |
Money from drug and device companies
$123 in 2020
| 2020 | 1 | 1 | None | $123 |
| 2019 | 2 | 2 | None | $70 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Otezla | $123 | 1 payment
|
See the published payment
| Amgen | Meals · 2020-02-20 | Otezla | $123 |
See earlier years (2019)
2019: $70
| Galderma Laboratories L.P. | None | $53 | 1 payment
|
| Ucb | Cimzia | $17 | 1 payment
|
Professional record
- NPI
- 1013335900
- Trained
- Stanford University School of Medicine, 2014
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 280 W Macarthur Blvd, Oakland, CA, 94611
- NPI first listed
- 2014-03-29
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.